Collegium Pharma (COLL) Misses Q2 EPS by 16c

Collegium Pharma (NASDAQ: COLL) reported Q2 EPS of ($0.45), $0.16 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Collegium Pharma (COLL) click here.

You May Also Be Interested In

• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• Collegium Pharmaceutical (COLL) PT Lowered to $48 at Barclays
• Advance Auto Parts falls on revenue miss, weak guidance